de Mattos AM et al. |
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. |
2000 |
Am. J. Kidney Dis. |
pmid:10676738
|
Kooman JP et al. |
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. |
2001 |
Am. J. Kidney Dis. |
pmid:11382685
|
Birdwell KA et al. |
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. |
2009 |
Am. J. Kidney Dis. |
pmid:19185404
|
First MR |
Renal transplantation for the nephrologist: new immunosuppressive drugs. |
1992 |
Am. J. Kidney Dis. |
pmid:1371201
|
Paoletti E et al. |
ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. |
2007 |
Am. J. Kidney Dis. |
pmid:17591533
|
Israni A et al. |
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877596
|
Cohen DL et al. |
Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients. |
2004 |
Am. J. Hypertens. |
pmid:15001192
|
Zhang W and Victor RG |
Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. |
2000 |
Am. J. Hypertens. |
pmid:10981550
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Nara M et al. |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3. |
2010 |
Am. J. Hematol. |
pmid:20568249
|
Lekakis LJ et al. |
BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. |
2009 |
Am. J. Hematol. |
pmid:19208419
|
Hammerstrom AE et al. |
Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. |
2013 |
Am. J. Hematol. |
pmid:23460378
|
Abdel-Azim H et al. |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. |
2015 |
Am. J. Hematol. |
pmid:26242764
|
Uehara T et al. |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. |
2004 |
Am. J. Hematol. |
pmid:15282671
|
Nakamae H et al. |
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. |
2006 |
Am. J. Hematol. |
pmid:16755559
|
Bolaños-Meade J et al. |
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. |
2005 |
Am. J. Hematol. |
pmid:15929116
|
Ninan MJ and Datta YH |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma. |
2010 |
Am. J. Hematol. |
pmid:20578201
|
Mach-Pascual S et al. |
Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. |
1996 |
Am. J. Hematol. |
pmid:8701950
|
Uehara T et al. |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. |
2002 |
Am. J. Hematol. |
pmid:12221672
|
Rudi J et al. |
Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. |
1997 |
Am. J. Gastroenterol. |
pmid:9317070
|
Van Thiel DH et al. |
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7532912
|
Baumgart DC et al. |
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. |
2006 |
Am. J. Gastroenterol. |
pmid:16573777
|
Sandborn WJ |
Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. |
1997 |
Am. J. Gastroenterol. |
pmid:9149205
|
Van Thiel DH et al. |
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7537444
|
Fellermann K et al. |
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). |
1998 |
Am. J. Gastroenterol. |
pmid:9772045
|
Stickle DF et al. |
Effects of sterilizing gamma irradiation on bloodspot newborn screening tests and whole blood cyclosporine and tacrolimus measurements. |
2003 |
Am. J. Clin. Pathol. |
pmid:12580001
|
Wang E et al. |
Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. |
2011 |
Am. J. Clin. Pathol. |
pmid:21228370
|
Burke MT et al. |
Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients. |
2015 |
Am. J. Clin. Pathol. |
pmid:25780003
|
Lower DR et al. |
Comparison of CEDIA FK506 assay with HPLC/MS/MS in a large cohort of pediatric patients. |
2013 |
Am. J. Clin. Pathol. |
pmid:23690122
|
Hisamura F et al. |
Synergistic effect of green tea polyphenols on their protection against FK506-induced cytotoxicity in renal cells. |
2008 |
Am. J. Chin. Med. |
pmid:18543393
|
Chung SY et al. |
Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain. |
2006 |
Am. J. Chin. Med. |
pmid:17080546
|
Chieffo A et al. |
Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. |
2009 |
Am. J. Cardiol. |
pmid:19962471
|
Chang RK et al. |
Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. |
1998 |
Am. J. Cardiol. |
pmid:9604971
|
Klauss V et al. |
Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. |
2000 |
Am. J. Cardiol. |
pmid:10955391
|
Herzberg GZ et al. |
Usefulness of tacrolimus versus cyclosporine after pediatric heart transplantation. |
1998 |
Am. J. Cardiol. |
pmid:9723652
|
Kodama M et al. |
FK506 therapy of experimental autoimmune myocarditis after onset of the disease. |
1993 |
Am. Heart J. |
pmid:7504393
|
Azizian M et al. |
Augmentation of ischemia/reperfusion injury to endothelial cells by cyclosporin A. |
2004 |
Am Surg |
pmid:15156953
|
Henderson CN et al. |
Continuous Abdominal Irrigation for Treatment of Tertiary Peritonitis in the Immunosuppressed Patient after Solid Organ Transplant: A Novel Approach. |
2017 |
Am Surg |
pmid:28424115
|
Rojas-GarcÃa P et al. |
Breast fibroadenomas associated with immunosuppressive drugs. |
2010 |
Am Surg |
pmid:21418766
|
Vearrier D et al. |
Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation. |
2011 |
Am J Ther |
pmid:20535006
|
Yang A and Wang B |
Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival. |
|
Am J Ther |
pmid:23921809
|
Pariser D |
Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. |
2009 May-Jun |
Am J Ther |
pmid:19262357
|
Sathyan S et al. |
Prevention of recurrent episodes of rhabdomyolysis with tacrolimus in a transplant recipient with myopathy. |
|
Am J Ther |
pmid:23429166
|
Liu JY et al. |
Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation. |
|
Am J Ther |
pmid:25299636
|
Haroon N et al. |
Tacrolimus Toxicity With Minimal Clinical Manifestations: A Case Report and Literature Review. |
|
Am J Ther |
pmid:25730156
|
Nunokawa T et al. |
Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report. |
|
Am J Ther |
pmid:22836123
|
Liu JY et al. |
Sirolimus Versus Tacrolimus as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation. |
|
Am J Ther |
pmid:25569597
|
Cohen SM |
Current immunosuppression in liver transplantation. |
2002 Mar-Apr |
Am J Ther |
pmid:11897926
|
Yousuf Bhat Z et al. |
Colchicine-Induced Myopathy in a Tacrolimus-Treated Renal Transplant Recipient: Case Report and Literature Review. |
|
Am J Ther |
pmid:24732905
|
Shin JH et al. |
The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis. |
2012 Mar-Apr |
Am J Rhinol Allergy |
pmid:22487280
|